profit from every ₹100 of sales.
₹0₹100
Krishna Institute of Medical Sciences
₹729.80+0.34% today
+15.1% in 1 year
1-year low ₹582.101-year high ₹850.65
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2023 to 2026.
0%20% a year
You pay ₹126.98 for every ₹1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Krishna Institute of Medical Sciences sold, what it kept, and what it did with the cash.
Sales went from ₹21.7 billion in 2023 to ₹39.0 billion in 2026, with ₹2.41 billion of profit last year.
SalesProfit
Krishna Institute of Medical Sciences vs. similar companies
Krishna Institute of Medical Sciences grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from ₹100 of sales | Sales growth a year | Price per ₹1 of profit |
|---|---|---|---|
| Krishna Institute of Medical Sciences | 127.0× · Very expensive | ||
 HCA Healthcare | 15.4× · Fair price | ||
 Fresenius SE & Co. KGaA | 23.9× · Fair price | ||
 IHH Healthcare Berhad | 34.3× · Expensive | ||
 Rede D'Or São Luiz | 16.2× · Fair price |
AI analysis
An AI analyst reads Krishna Institute of Medical Sciences's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 21,677 | 24,740 | 30,350 | 39,046 | |
| 13,406 | 15,212 | 19,086 | 24,140 | |
| 4,895 | 5,025 | 6,056 | 5,188 | |
| 6,435 | 6,524 | 8,256 | 8,196 | |
| 3,363 | 3,100 | 3,845 | 2,414 | |
| 8.41 | 7.75 | 9.61 | – | |
| 61.8% | 61.5% | 62.9% | 61.8% | |
| 22.6% | 20.3% | 20.0% | 13.3% | |
| 15.5% | 12.5% | 12.7% | 6.2% |
Balance sheet
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Total assets | 29,413 | 38,517 | 57,360 | 77,587 |
| Cash | 616 | 469 | 560 | 554 |
| Total debt | 6,782 | 13,555 | 25,567 | 42,529 |
| Total liabilities | 10,033 | 17,586 | 33,172 | 52,002 |
| 16,695 | 18,282 | 21,378 | 22,474 | |
| 400 | 400 | 400 | – | |
| 16.4% | 11.9% | 10.4% | 6.2% | |
| 20.1% | 17.0% | 18.0% | 10.7% |
Cash flow
| In millions of INR | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| 4,321 | 5,212 | 5,818 | 5,108 | |
| 5,745 | 6,473 | 10,089 | 14,279 | |
| -1,424 | -1,261 | -4,271 | -9,171 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 127.0×
- –
- –
- 13.6×
- 7.9×
- –
- 42.5×
- -3.0%
- 0.8%
- –
Profitability
- 61.8%
- 13.3%
- 6.2%
- –
- 6.2%
- 11.2%
- –
- –
- –
- –
Growth
- +21.7%
- –
- –
- –
- +0.2%
Financial health
- 5.1×
- 1.89
- –
- 2.6×
- 0.76
- –
- –
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Top 45%of 946
Top 40%of 872
Bottom 6%of 563
Top 27%of 868
Bottom 26%of 986
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
30No pass
Benjamin Graham
22No pass
Philip Fisher
43No pass
Peter Lynch
60Pass
Joel Greenblatt
2No pass
Charlie Munger
23No pass
Terry Smith
21No pass
Questions about Krishna Institute of Medical Sciences
Is Krishna Institute of Medical Sciences a good stock to buy?
A business with weak numbers, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Krishna Institute of Medical Sciences AI analysis
What does Krishna Institute of Medical Sciences do?
Krishna Institute of Medical Sciences Limited provides medical and health care services under the KIMS Hospitals brand in India. It is in Medical Care Facilities, based in Secunderabad, India.
Is Krishna Institute of Medical Sciences stock halal?
Yes. Krishna Institute of Medical Sciences passes our halal screen: its business is permitted and its debt is 14% of its market value, under the 30% limit. How we check
How has Krishna Institute of Medical Sciences stock done over the past year?
Up 15.1% over the past twelve months, to ₹729.80. It traded between ₹582.10 and ₹850.65 and is 14.2% below its high.
Who are Krishna Institute of Medical Sciences's competitors?
The largest listed companies in the same industry are HCA Healthcare, Fresenius SE & Co. KGaA, IHH Healthcare Berhad and Rede D'Or São Luiz. The peers table on this page compares their profit, growth and price with Krishna Institute of Medical Sciences's.
Prices: daily closes to Nov 13, 2026. Fundamentals: company reports via invest-like data.